Symmetric dimethylarginine (SDMA) is an amino acid derivative released into the bloodstream during protein degradation. It is primarily eliminated from the body via renal excretion. Elevated levels of this molecule in canine patients often indicate a reduction in kidney function. Consequently, measuring the concentration of this substance in blood samples provides a valuable indicator of renal health in dogs.
The identification of elevated levels offers a significant advantage in veterinary diagnostics. Early detection of diminished kidney function allows for timely intervention and management strategies. This proactive approach can lead to improved outcomes for affected animals, potentially extending their lifespan and enhancing their quality of life. Its introduction as a diagnostic marker represents a notable advancement in veterinary internal medicine.
